Key Insights

Highlights

Success Rate

85% trial completion

Research Maturity

63 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.0%

11 terminated out of 122 trials

Success Rate

85.1%

-1.4% vs benchmark

Late-Stage Pipeline

11%

14 trials in Phase 3/4

Results Transparency

13%

8 of 63 completed with results

Key Signals

8 with results85% success11 terminated

Data Visualizations

Phase Distribution

64Total
Not Applicable (32)
Early P 1 (1)
P 1 (6)
P 2 (11)
P 3 (9)
P 4 (5)

Trial Status

Completed63
Unknown23
Recruiting13
Terminated11
Active Not Recruiting6
Not Yet Recruiting3

Trial Success Rate

85.1%

Benchmark: 86.5%

Based on 63 completed trials

Clinical Trials (122)

Showing 20 of 20 trials
NCT06018766Phase 2Recruiting

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.

NCT06948097Phase 1Not Yet RecruitingPrimary

Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies

NCT07525440CompletedPrimary

Neural Respiratory Drive Combined With Pro-Brain Natriuretic Peptide (Pro-BNP) as Predictor of Deterioration After Lung Transplantation

NCT06795516TerminatedPrimary

Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation

NCT03798860CompletedPrimary

Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

NCT07479511Active Not RecruitingPrimary

Adaptation of Lung Transplant Recipients at Extreme Altitude

NCT05689905CompletedPrimary

Immunologic Risk of Pregnancy in Women With Lung Transplantion : a National Multicentric Study

NCT05837663RecruitingPrimary

Trifecta-Lung cfDNA-MMDx Study

NCT07356752Not ApplicableActive Not Recruiting

Prediction of Lung Transplant Outcome

NCT06853223Phase 2Recruiting

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

NCT07316829Active Not Recruiting

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

NCT07291258Recruiting

Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

NCT05309551Not ApplicableActive Not RecruitingPrimary

Inspiratory Muscle Training Immediately After Lung Transplantation

NCT01294020Phase 2Completed

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

NCT07251777Not ApplicableCompleted

Prone vs Supine Position in Potential Organ Donors: Multicenter Clinical Trial

NCT06963190Not ApplicableEnrolling By InvitationPrimary

Impact of Inspiratory Muscle Training (IMT) With Intermittent Variable Resistance (IVR) Versus Constant Resistance (CR) on Functional Capacity in Lung Transplantation (LTx) Patients (I-TRAIN-LTx Study)

NCT03639025Active Not RecruitingPrimary

OCS™ Lung TOP Registry For Donor Lungs for Transplantation

NCT06218745CompletedPrimary

Prediction Model for Postoperative AKI in Patients Undergoing Lung Transplantation Using Machine Learning

NCT06218758CompletedPrimary

Prediction Model for PPCs in Patients Undergoing Lung Transplantation Using Machine Learning

NCT00552357Recruiting

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

Scroll to load more

Research Network

Activity Timeline